Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

ARK Genomic Revolution ETF (NY:ARKG)

24.30 -0.26 (-1.06%)
Official Closing Price Updated: 8:00 PM EDT, Jun 27, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about ARK Genomic Revolution ETF

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Cathie Wood's Ark Invest Adds Airbnb, AMD, Shopify To Portfolio, Slashes Stake In Circle Internet
Via Benzinga
Oracle, AST SpaceMobile And Halliburton Are Among Top 10 Large Cap Gainers Last Week (June 9-13): Are The Others In Your Portfolio?
Top 10 large-cap stocks with biggest gains last week: INSM, CRCL, ORCL, ASTS, SAIL, VG, TEM, CASY, EQNR, HAL. Have you invested in them? 
Via Benzinga
Cathie Wood Just Flagged The Start Of A Biotech Revolution: These 2 Stocks With 10x Potential Are Leading It
Cathie Wood is bullish on biotech companies using gene sequencing, AI, and CRISPR tech to cure previously untreatable diseases. 
Via Benzinga
Topics Artificial Intelligence
Cathie Wood's Ark Invest Continues To Offload Tesla As Elon Musk Moves On From Trump Administration
Ark Invest made significant trades in TSLA, TXG, NTLA, DDD, and ADPT. Purchase of TXG and NTLA from ARKG and ARKK funds, and sale of TSLA, DDD, and ADPT from various funds. 
Via Benzinga
Topics Government
Cathie Wood Ditches $5.6M More Tesla While Elon Musk Quits Government Role — Doubles Down On AI Stock Under Attack By Short Sellers
ARK Invest, led by Cathie Wood, made significant trades involving Tesla and Tempus AI amid insider sales and short seller scrutiny. $5.6 million in Tesla shares sold, $13.36 million in Tempus AI shares... 
Via Benzinga
Topics Artificial Intelligence
Genetic Data From 23andMe Ends Up With This Company In $256 Million Deal
Regeneron (REGN) to acquire 23andMe for $256 million, plans to maintain consumer services and uphold privacy policies. Deal expected to close Q3 2025. 
Via Benzinga
Cathie Wood's Ark Invest Offloads Uipath, Prime Medicine, And Repare Therapeutics
On April 11th, 2025, Cathie Wood's Ark Invest sold shares in UiPath, Prime Medicine, and Repare Therapeutics, with notable gains and losses. 
Via Benzinga
Cathie Wood's Ark Invest Loads Up On Robinhood, Nvidia-Backed CoreWeave: Offloads Spotify, Roku
Cathie Wood-led Ark Invest made substantial trades, buying Robinhood and CoreWeave shares and selling Roblox, Genius Sports, Roku, and Spotify shares. 
Via Benzinga
Cathie Wood's Ark Invest Scoops Up Iridium, Beam, Pacific Biosciences While Offloading Illumina And Amgen
Cathie Wood-led Ark Invest made notable trades, buying IRDM, BEAM, PACB, ABSI and selling ILMN, RPTX, AMGN, VEEV. 
Via Benzinga
Cathie Wood's Big Tuesday Bet: Ark Pours $7.8 Million Into Tempus AI Despite Stock Stumble
On Tuesday, March 18, 2025, Ark Invest, led by Cathie Wood, purchased $7.83 million shares of Tempus AI. 
Via Benzinga
Topics Artificial Intelligence
Cathie Wood's Ark Invest Continues To Offload UiPath, Roblox: Loads Up On GitLab, Ibotta
Ark Invest's Cathie Wood-led funds made significant trades involving GitLab, Intellia, Prime Medicine, UiPath, Ibotta, Roblox, Repare Therapeutics, and CareDx. 
Via Benzinga
Healthcare Stocks Doing Well But SMID Biotech Looking A Little Frazzled
Small caps took another step down this past week as geopolitical events dampened sentiment. 
Via Talk Markets
Topics ETFs Stocks / Equities
Cathie Wood Smelling AI Opportunity? Ark Invest Buys Tempus AI Dip, Scoops Up Over $13 M Worth Of Stock
On Thursday, March 6, 2025 Ark Invest made significant trades in Tempus AI and GitLab, increasing its tech and AI exposure after their earnings reports, while also adjusting positions in other stocks. 
Via Benzinga
Topics Artificial Intelligence
Biotech Rally Coming In Weeks Ahead?
Large cap biopharma and MedTech stocks are leading the healthcare sector higher. 
Via Talk Markets
Topics ETFs Stocks / Equities
Cathie Wood's Monday Moves: Ark Buys Tempus AI Dip And Airbnb Spike— Goes Shopping For Coinbase Stock Amid Trump Tariff Crypto Meltdown
On Monday, Cathie Wood‘s Ark Invest executed significant trades involving Airbnb Inc. (NASDAQ:ABNB), Coinbase Global Inc. (NASDAQ:COIN), Tempus AI Inc. (NASDAQ: 
Via Benzinga
Topics Artificial Intelligence Government
Cathie Wood's Ark Invest Loads Up On Tempus AI, Archer Aviation, But Sells Twist Bioscience: Here Are Key Ark Trades This Friday
Ark Invest made notable trades on Feb. 28, 2025. They purchased shares in ACHR, RXRX, TEM, and IRDM, while selling shares in TWST, ADYEY, ACCD, and EXAS. 
Via Benzinga
Topics Artificial Intelligence
Cathie Wood's Buys The Dip In Tempus AI, Coinbase But Sells Ark's Bitcoin ETF Shares Amid Crypto Meltdown
On Tuesday, Cathie Wood-led Ark Invest made some significant trades, most notably buying into Tempus AI Inc. (NASDAQ:TEM) and Coinbase Global Inc. 
Via Benzinga
Topics Artificial Intelligence ETFs
Rocket Lab, Kratos, Archer Aviation And More Earnings This Week Could Have A Big Impact On Cathie Wood's Ark ETFs
Several top Cathie Wood holdings in the Ark Funds ETFs report quarterly results the week of Feb. 24 through Feb. 28. 
Via Benzinga
Topics ETFs
Synchronicity: Denying The Unexplainable
Elon Musk and Neurolinks has been loud about the singularity—AI surpassing human intelligence. But has curiosity has lost its oomph? 
Via Talk Markets
Topics Stocks / Equities
NIH Funding Cuts To Spook Healthcare Stocks? RFK Jr's Confirmation At HHS Sparks Concerns Over Research Dollars, 'Causing Uncertainty,' Says Analyst
Robert F. Kennedy Jr.'s appointment as Secretary of Health and Human Services has sparked concerns over funding for the NIH. 
Via Benzinga
Cathie Wood's Ark Invest Loads Up On Beam Therapeutics, Nu Holdings: Offloads MercadoLibre, Adaptive Biotechnologies
Via Benzinga
Biotech Stocks Had A Good Week Despite Crosscurrents
It’s too early to account for the rally but in general one can say that there is a lot of speculation from both the retail side and hedge funds. 
Via Talk Markets
Topics ETFs Stocks / Equities
Cathie Wood's Ark Invest Loads Up On Iridium, Twist Bioscience, Offloads Roku: Here Are Key Ark Trades This Friday
Cathie Wood-led Ark Invest made trades involving IRDM, TWST, PD, BEAM, ROKU, and IBTA. 
Via Benzinga
Tempus AI Executives Sell $20 Million In Stock As Cathie Wood Buys And Nancy Pelosi Eyes Options
Multiple executives at Tempus AI Inc. executed significant share sales totaling $20.3 million between Feb. 4-7, according to recent Securities and Exchange Commission filings. The transactions occurred... 
Via Benzinga
Topics Artificial Intelligence
Cathie Wood's Ark Invest Bets Big On Amazon, Roblox And Illumina While Trimming Palantir Stake After Alex Karp-Led Company Touched An All-Time High On Thursday
Ark Invest made significant trades on Friday, including buying Amazon and Roblox stock and selling Palantir stock. Other key trades were also made. 
Via Benzinga
Small- To Mid-Cap Biotech Trades Poised For Gains
On Monday, we called for a trading bottom in healthcare stocks. We also saw momentum picking for two Health Science sectors: small- to mid-cap biotechs, and MedTech. Here is a closer look at these... 
Via Talk Markets
Topics ETFs Stocks / Equities
Cathie Wood's Ark Invest Bets On Biotech With CRISPR Therapeutics Investment, Exits Roblox
Cathie Wood-led Ark Invest made significant trades involving CRSP, TXG, RBLX, ACHR, NU, ADYEY, ACCD, and AVAV. 
Via Benzinga
ETFs Shine As S&P 500 Hits Record High: Top 5 ETFs With Best Gains From Last Week
Global economy and financial markets saw a lot of activity in Jan. 24 week. S&P 500 reached record high, several ETFs had double-digit gains. 
Via Benzinga
Topics ETFs Economy Stocks
Intellia Stock Dips After Morgan Stanley Downgrade, Retail Sentiment Weakens
The brokerage pointed to the company’s recent discontinuation of its NTLA-3001 program for alpha-1 antitrypsin deficiency-associated lung disease, reducing near-term growth prospects. 
Via Stocktwits
Tempus AI Stock Eyes Best Rally In 5 Months Amid Pelosi-Linked Hype, But Retail’s Turning Doubtful Now
A regulatory filing from Wednesday night disclosed that Tempus AI founder and CEO Eric Lefkofsky sold 946,084 shares of Tempus between Jan. 15-17. 
Via Stocktwits
Topics Artificial Intelligence
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.